Literature DB >> 25185463

Transanal total mesorectal excision in rectal cancer: short-term outcomes in comparison with laparoscopic surgery.

María Fernández-Hevia1, Salvadora Delgado, Antoni Castells, Marta Tasende, Dulce Momblan, Gabriel Díaz del Gobbo, Borja DeLacy, Jaume Balust, Antonio M Lacy.   

Abstract

OBJECTIVE: The aim of this study was to compare short-term results obtained with transanal total mesorectal excision (TME) and laparoscopic surgery.
BACKGROUND: Transanal TME appears as an alternative in the treatment of rectal cancer and other rectal disease. Natural orifices transluminal endoscopic surgery using the rectum as access in colorectal surgery is intuitively better suited than other access routes.
METHODS: All consecutive patients with middle or low rectal cancer submitted to surgery were included into a prospective cohort and treated by transanal TME assisted by laparoscopy. They were compared with a retrospective cohort of consecutive patients of identical characteristics treated by laparoscopic TME in the immediate chronological period.
RESULTS: Thirty-seven patients were included in both study groups. No differences were observed between them with respect to baseline characteristics, thus emphasizing the comparability of both cohorts. Surgical time was higher in the laparoscopy group (252 ± 50 minutes) than in the transanal group (215 ± 60 minutes) (P < 0.01). Moreover, coloanal anastomosis was performed less frequently (16% vs 43%, respectively; P = 0.01) and distal margin was lower (1.8 ± 1.2 mm vs 2.7 ± 1.7 mm, respectively; P = 0.05) in the laparoscopy group than in the transanal one. Although there was no significant difference in 30-day postoperative complication rate (laparoscopy, 51% vs transanal, 32%; P = 0.16), early readmissions were more frequent in the laparoscopy group than in the transanal one (22% vs 6%, respectively; P = 0.03).
CONCLUSIONS: Evaluation of short-term outcomes demonstrated that transanal TME is a feasible and safe technique associated with a shorter surgical time and a lower early readmission rate.

Entities:  

Mesh:

Year:  2015        PMID: 25185463     DOI: 10.1097/SLA.0000000000000865

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  94 in total

1.  Transanal total mesorectal excision for rectal cancer: a preliminary report.

Authors:  Liang Kang; Wen-Hao Chen; Shuang-Ling Luo; Yan-Xin Luo; Zhi-Hua Liu; Mei-Jin Huang; Jian-Ping Wang
Journal:  Surg Endosc       Date:  2015-08-27       Impact factor: 4.584

2.  Midterm functional results of taTME with neuromapping for low rectal cancer.

Authors:  W Kneist; N Wachter; M Paschold; D W Kauff; A D Rink; H Lang
Journal:  Tech Coloproctol       Date:  2015-11-11       Impact factor: 3.781

Review 3.  Transanal Minimally Invasive Surgery: State of the Art.

Authors:  D S Keller; E M Haas
Journal:  J Gastrointest Surg       Date:  2015-11-25       Impact factor: 3.452

4.  Transperineal minimally invasive approach for extralevator abdominoperineal excision.

Authors:  Suguru Hasegawa; Tomoaki Okada; Koya Hida; Kenji Kawada; Yoshiharu Sakai
Journal:  Surg Endosc       Date:  2015-12-30       Impact factor: 4.584

5.  Combined transanal total mesorectal excision (taTME) with laparoscopic instruments and abdominal robotic surgery in rectal cancer.

Authors:  R Bravo; J-S Trépanier; M C Arroyave; M Fernández-Hevia; A Pigazzi; A M Lacy
Journal:  Tech Coloproctol       Date:  2017-03-06       Impact factor: 3.781

6.  Transanal total mesorectal excision (taTME) in a single-surgeon setting: refinements of the technique during the learning phase.

Authors:  A Caycedo-Marulanda; G Ma; H Y Jiang
Journal:  Tech Coloproctol       Date:  2018-06-28       Impact factor: 3.781

7.  Transanal Total Mesorectal Excision for Treatment of Carcinoma in the Middle or Lower Third Rectum: the Technical Feasibility of the Procedure, Pathological Results, and Clinical Outcome.

Authors:  Ashraf M Abdelkader; Ahmed M Zidan; Mohamed T Younis; Shaimaa K Dawa
Journal:  Indian J Surg Oncol       Date:  2018-08-04

Review 8.  Transanal endoscopic microsurgery for rectal cancer: T1 and beyond? An evidence-based review.

Authors:  Marco E Allaix; Alberto Arezzo; Mario Morino
Journal:  Surg Endosc       Date:  2016-02-22       Impact factor: 4.584

9.  Transanal total mesorectal excision: full steam ahead.

Authors:  S Atallah
Journal:  Tech Coloproctol       Date:  2015-01-06       Impact factor: 3.781

10.  Study protocol for a multicenter prospective controlled and randomized trial of transanal total mesorectal excision versus laparoscopic low anterior resection in rectal cancer.

Authors:  X Serra-Aracil; A Zárate; L Mora; S Serra-Pla; A Pallisera; J Bonfill; J Bargalló; A Pando; S Delgado; E Balleteros; C Pericay
Journal:  Int J Colorectal Dis       Date:  2018-03-16       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.